To validate the regulatory role of the SET-ZBTB11 complex under more physiological conditions, we disrupted the SET-ZBTB11 interaction by interfering with endogenous SET and/or ZBTB11 to evaluate potential alterations in cancer cell behaviors in H1299 cells (Fig. 4k). The gene discussed is ZBTB11; the disease is cancer.